‌

US Patent 10626081 Farnesoid X receptor agonists and uses thereof

Patent 10626081 was granted and assigned to Metacrine on April, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Metacrine

Current Assignee

Metacrine

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10626081

Date of Patent

April 21, 2020

Patent Application Number

15758709

Date Filed

September 16, 2016

Patent Citations Received

‌

US Patent 11993613 Thiazolo[5,4-b]pyridine MALT-1 inhibitors

‌

US Patent 11236071 Farnesoid X receptor agonists and uses thereof

‌

US Patent 11773094 Farnesoid X receptor agonists and uses thereof

Patent Primary Examiner

‌

Heidi Reese

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10626081 Farnesoid X receptor agonists and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API